2m 2m 2m 2m 2m 2m 2m
VERA THERAPEUT-A (VERA)
NASDAQ
$38.35-$0.08 (-0.21%)
Price as of Jun 23, 2026 6:08 PM EDT- $2.8BMarket Cap
- 77.51%1-Year Change
- BiotechnologyIndustry
VERA THERAPEUT-A (VERA)
$38.35-$0.08 (-0.21%)
VERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.43 | ||
Change | +$3.34 (+9.52%) | ||
Open | $35.97 | ||
High | $38.67 | ||
Low | $35.95 | ||
Previous Close | $35.09 | ||
Volume | 1,779,985 | ||
30-Day Average Volume | 1,200,500 | ||
1-Week Change | 12.24% | ||
1-Month Change | 12.90% | ||
1-Year Change | 77.51% | ||
3-Year Change | 144.00% | ||
5-Year Change | 142.61% | ||
Fundamentals | |||
Shares Outstanding | 71.8M | ||
Total Assets | $621.7M | ||
Market Cap | $2.8B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | -$942,000.00 | ||
Net Income | -$121.0M | ||
Free Cash Flow | -$106.5M | ||
EBIT | -$121.0M | ||
EBITDA | -$120.9M | ||
Net Working Capital | $570.7M | ||
EPS | -$1.69 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | -2,887 | ||
P/B | 6 | ||
P/E | -23 | ||
PEG | 1 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue